Sodium-Glucose Cotransporter 2 Inhibitors and the Risk of Pneumonia and Septic Shock. Li HL, Tse YK, Chandramouli C, Hon NW, et al. J Clin Endocrinol Metab 2022;107:3442-3451.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Li HL, Tse YK, Chandramouli C, Hon NW, et al. Sodium-Glucose Cotransporter 2 Inhibitors and the Risk of Pneumonia and Septic Shock. J Clin Endocrinol Metab 2022;107:3442-3451.
PMID: 36181458